EUVIMEDEUVIMED entdecken
Open Access

Is programmed death-ligand 1 positivity a predictor of poor survival in patients with different histological subtypes of pancreatic cancer?

Ceren Canbey iD, Sena Şen iD, Senem Karabulut iD, Tevhide Bilgen Özcan iD, Esra Paşaoğlu iD, Eren Altun iD, Taha Yusuf Kuzan iD, Fikret Ezberci iD

Cytojournal · 06.05.2025 · 22 · 47

DOI: 10.25259/cytojournal_2_2025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cytojournal, online erschienen am 06.05.2025. Verfasst von Ceren Canbey und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine Pathology, Bagcilar Research and Training Hospital, Istanbul, Türkiye. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Pancreatic cancer is the cancer type with the highest mortality rate worldwide, and despite advances in treatment, molecular biomarkers are needed for both early diagnosis for developing targeted therapies and improving survival rates in this challenging malignancy. In our study, the contributions of programmed death-ligand 1 (PD-L1) expression to the determination of pancreatic cancer subtypes and patient prognosis and its impact on survival were investigated. Material and Methods Paraffin-embedded tissues from 92 patients diagnosed with pancreatic cancer were included in this study. Tumor-infiltrating lymphocytes (TILs) and lymphocytes in the stromal area within the tumor borders were scored as stromal TILs; lymphocytes in tumor islands were scored as intratumoral TILs. Staining in each area was scored as a percentage, and staining with a score of 5 or more in tumor and immune cells for PD-L1 was scored as positive.

Results

After staining, a score of 5 or more with tPD-L1 staining was used to identify one patient as having micropapillary adenocarcinoma, three patients as having ductal adenocarcinoma, and four patients as having signet ring cell carcinoma. When the clinical parameters and outcomes were compared, a statistically significant difference was found between the histopathologic type of signet ring cell carcinoma and poor differentiation and positivity of PD-L1 expression ( P < 0.05). Survival was significantly influenced by tumor location, histopathological subtype, degree of differentiation, PD-L1 expression, and tumor size, with tumor size being the most critical factor ( P < 0.05).

Conclusion

Our findings suggest that PD-L1 positivity is notably prevalent in signet ring cell carcinoma of the pancreas and is strongly associated with poor survival outcomes. Given these results, further studies with larger patient cohorts are warranted to validate these observations and explore potential therapeutic implications.

Schlagwörter

Stichwörter der Autor:innen

BiomarkerImmunohistochemistryPancreatic cancerProgrammed cell death ligand 1

Autor:innen und Institutionen

  • Department of Medicine Pathology, Bagcilar Research and Training Hospital, Istanbul, Türkiye.
  • Department of Molecular Oncology, Hamidiye Health Sciences Institute, University of Health Sciences, Istanbul, Türkiye.
  • Department of Basic Oncology, Oncology Institute, Istanbul University, Istanbul, Türkiye.
  • Department of Clinic Oncology, Oncology Institute, Istanbul University, Istanbul, Türkiye.
  • Sancaktepe Martyr Prof Dr İlhan Varank Research and Training Hospital, Istanbul, Türkiye.
  • Department of General Surgery, Umraniye Education and Research Hospital, University of Health Sciences, Istanbul, Türkiye.

ORCID-Profile: Ceren Canbey, Sena Şen, Senem Karabulut, Tevhide Bilgen Özcan, Esra Paşaoğlu, Eren Altun, Taha Yusuf Kuzan, Fikret Ezberci

Zitieren

APA

Canbey, C., Şen, S., Karabulut, S., Özcan, T. B., Paşaoğlu, E., Altun, E., Kuzan, T. Y., & Ezberci, F. (2025). Is programmed death-ligand 1 positivity a predictor of poor survival in patients with different histological subtypes of pancreatic cancer?. Cytojournal, 22, 47. https://doi.org/10.25259/cytojournal_2_2025

Vancouver

Canbey C, Şen S, Karabulut S, Özcan TB, Paşaoğlu E, Altun E, et al. Is programmed death-ligand 1 positivity a predictor of poor survival in patients with different histological subtypes of pancreatic cancer?. Cytojournal. 2025;22:47. doi:10.25259/cytojournal_2_2025

BibTeX
@article{Canbey2025,
  author = {Canbey, Ceren and Şen, Sena and Karabulut, Senem and Özcan, Tevhide Bilgen and Paşaoğlu, Esra and Altun, Eren and Kuzan, Taha Yusuf and Ezberci, Fikret},
  title = {Is programmed death-ligand 1 positivity a predictor of poor survival in patients with different histological subtypes of pancreatic cancer?},
  journal = {Cytojournal},
  year = {2025},
  volume = {22},
  pages = {47},
  doi = {10.25259/cytojournal_2_2025}
}
Kostenlos starten →